FDA approves first gene therapies to treat sickle cell disease

FDA approves first gene therapies to treat sickle cell disease

Newsy

Published

ViewTwo gene therapies that the Food and Drug Administration describes as "milestones" were approved Friday for treatment of sickle cell disease.

The Centers for Disease Control and Prevention says 100,000 Americans are living with sickle cell disease, which disproportionately affects Black and Hispanic individuals.

"The...

Full Article